x
Filter:
Filters applied
- Clinical Practice Guidelines and Recommendations
- LDL-CRemove LDL-C filter
- CVDRemove CVD filter
Author
- Kopecky, Stephen L2
- Lopez-Jimenez, Francisco2
- Allison, Thomas G1
- Basu, Ananda1
- Blaha, Michael J1
- Blumenthal, Roger S1
- Cainzos-Achirica, Miguel1
- Desai, Chintan S1
- Fernandes, Regis1
- Hurst, R Todd1
- Kullo, Iftikhar J1
- Martin, Seth S1
- Mulvagh, Sharon L1
- Myers, Jonathan1
- Simha, Vinaya1
- Thomas, Randal J1
- Thompson, Warren G1
- Trejo-Gutierrez, Jorge F1
- Wang, Libin1
- Wright, R Scott1
Keyword
- cardiovascular disease3
- low-density lipoprotein cholesterol3
- ACC/AHA2
- Adult Treatment Panel III2
- American College of Cardiology/American Heart Association2
- ASCVD2
- ATP III2
- CAD2
- CHD2
- coronary artery disease2
- 4S1
- A to Z1
- ABI1
- ACC1
- ACCORD1
- Action to Control Cardiovascular Risk in Diabetes1
- AFCAPS-TexCAPS1
- Aggrastat to Zocor1
- AHA1
- Air Force/Texas Coronary Atherosclerosis Prevention Study1
- ALT1
- ASCOT-LLA1
- ASPEN1
Clinical Practice Guidelines and Recommendations
3 Results
- Review
Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines
Mayo Clinic ProceedingsVol. 90Issue 9p1262–1271Published online: August 11, 2015- Miguel Cainzos-Achirica
- Chintan S. Desai
- Libin Wang
- Michael J. Blaha
- Francisco Lopez-Jimenez
- Stephen L. Kopecky
- and others
Cited in Scopus: 16The 2013 American College of Cardiology/American Heart Association cardiovascular disease prevention guidelines represent an important step forward in the risk assessment and management of atherosclerotic cardiovascular disease in clinical practice. Differentiated risk prediction equations for women and black individuals were developed, and convenient 10-year and lifetime risk assessment tools were provided, facilitating their implementation. Lifestyle modification was portrayed as the foundation of preventive therapy. - Special article
A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps
Mayo Clinic ProceedingsVol. 89Issue 9p1257–1278Published online: August 13, 2014- Francisco Lopez-Jimenez
- Vinaya Simha
- Randal J. Thomas
- Thomas G. Allison
- Ananda Basu
- Regis Fernandes
- and others
Cited in Scopus: 36The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines has recently released the new cholesterol treatment guideline. This update was based on a systematic review of the evidence and replaces the previous guidelines from 2002 that were widely accepted and implemented in clinical practice. The new cholesterol treatment guideline emphasizes matching the intensity of statin treatment to the level of atherosclerotic cardiovascular disease (ASCVD) risk and replaces the old paradigm of pursuing low-density lipoprotein cholesterol targets. - Commentary
New American Heart Association/American College of Cardiology Guidelines on Cardiovascular Risk: When Will Fitness Get the Recognition It Deserves?
Mayo Clinic ProceedingsVol. 89Issue 6p722–726Published online: May 5, 2014- Jonathan Myers
Cited in Scopus: 22During the American Heart Association (AHA) Scientific Sessions in November 2013, the AHA and the American College of Cardiology (ACC) jointly released new guidelines for the prevention and treatment of coronary artery disease (CAD). The guidelines focused on the assessment of cardiovascular risk1 and the treatment of blood lipids2 and received a great deal of attention from both the media and professional journals. These organizations are among the most experienced and qualified to develop guidelines, and their guidelines and scientific statements set the standard for clinical practice.